Mednet Logo

For an otherwise healthy post-menopausal woman with early stage HR+ BC and persistent AI intolerance, is there an age cutoff above which you would consider avoiding adjuvant tamoxifen therapy?

The patient has an intact uterus and has failed all available AI therapies due to multiple intolerances.
1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Icahn School of Medicine at Mount Sinai
Answered on

There is no age cut-off based on chronological age. However, physiologic age and comorbid conditions are what I would use. For example, a 72 yo with diabetes, hypertension, and coronary artery disease is likely to die of her underlying conditions and not early stage breast cancer (Ording et al., PMI...

Join for free or sign in to see the full answer